131193-37-8

Basic information

• Product Name: ethyl 3-<2-(4-hydroxy-3-methoxyphenyl)ethenyl>-1H-pyrazole-5-carboxylate
• Synonyms: ethyl 3-<2-(4-hydroxy-3-methoxyphenyl)ethenyl>-1H-pyrazole-5-carboxylate
• CAS NO: 131193-37-8
• Molecular Weight: 288.303
• Mol File: 131193-37-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: ethyl 3-<2-(4-hydroxy-3-methoxyphenyl)ethenyl>-1H-pyrazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-<2-(4-hydroxy-3-methoxyphenyl)ethenyl>-1H-pyrazole-5-carboxylate(131193-37-8)
• EPA Substance Registry System: ethyl 3-<2-(4-hydroxy-3-methoxyphenyl)ethenyl>-1H-pyrazole-5-carboxylate(131193-37-8)

Safety Data

• Hazardous Substances Data: 131193-37-8(Hazardous Substances Data)

Upstream product

• 113465-70-6 ethyl 6-(4-hydroxy-3-methoxyphenyl)-2,4-dioxo-5-hexenoate 

Downstream Products

• 131068-28-5 3-[β-(3-Methoxy-4-hydroxyphenyl)ethenyl]-1H-pyrazole-5-carboxylic acid 

Relevant articles and documents

Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

Amide compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them

-